HRT Financial’s Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share BOXD.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-104,735
Closed -$4K 3521
2022
Q4
$4K Hold
104,735
﹤0.01% 2298
2022
Q3
$9K Hold
104,735
﹤0.01% 2549
2022
Q2
$22K Sell
104,735
-2,145
-2% -$1.8K ﹤0.01% 2596
2022
Q1
$114K Buy
106,880
+2,605
+2% +$2.47K ﹤0.01% 2626
2021
Q4
$124K Buy
+104,275
New +$94.7K ﹤0.01% 2697

Other funds holding BOXD.WS

HRT Financial's BOXD.WS Position: Q1 2023 in Review

HRT Financial sold out of Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share (BOXD.WS) in Q1 2023, closing a stake of 104,735 shares — an estimated $4K sold.

HRT Financial first reported a position in BOXD.WS in Q4 2021 and held it in 5 quarters. The position peaked at $124K in Q4 2021. 7 funds tracked by Wall St. Rank hold BOXD.WS as of Q1 2023.

  • HRT Financial reported no remaining Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 104,735 Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2023, an estimated $4K.
  • HRT Financial first reported a position in Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 5 quarters.
  • HRT Financial's Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share position peaked at $124K in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.